《Thoracic Cancer》重点专注发布ONCOLOGY-RESPIRATORY SYSTEM领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在ONCOLOGY-RESPIRATORY SYSTEM领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 5.2 | 0.778 | 0.785 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：PulmonaryandRespiratoryMedicine
|
Q2 | 54/155 | 65% | |||
|
大类：大类：Medicine
小类：小类：Oncology
|
Q2 | 160/404 | 60% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q3 | 201 / 322 | 37.7% |
| 学科：RESPIRATORY SYSTEM | SCIE | Q2 | 50 / 100 | 50.5% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q3 | 177 / 322 | 45.19% |
| 学科：RESPIRATORY SYSTEM | SCIE | Q2 | 50 / 101 | 50.99% |
文章名称
引用次数
Epidemiology of lung cancer in China
58
Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease
26
ALK-rearrangement in non-small-cell lung cancer (NSCLC)
22
Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p
20
Role of long non-coding RNA in drug resistance in non-small cell lung cancer
18
High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma
17
Comprehensive analysis of circular RNA profiling in AZD9291-resistant non-small cell lung cancer cell lines
17
Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer
16
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients
15
Risk factors of lymph node metastasis in patients with non-small cell lung cancer <= 2 cm in size: A monocentric population-based analysis
13
国家/地区
发文量
TCHINA MAINLAND
712
TJapan
203
TSouth Korea
83
TUSA
39
TTaiwan
27
TItaly
21
TSpain
9
TMexico
7
TEngland
6
TAustria
5
